Lung inflammation

B7-33 exhibits a powerful anti-fibrotic effect. It has been shown that it may minimize the production of excessive scar tissue after heart damage. Additionally, it has shown potential in the treatment of certain vascular problems as well as the preeclampsia that may occur during pregnancy. - Anti-Fibrotic Properties - Blood Vessel Protection - Acute heart failure - Lung inflammation

B7-33 exhibits a powerful anti-fibrotic effect. It has been shown that it may minimize the production of excessive scar tissue after heart damage. Additionally, it has shown potential in the treatment of certain vascular problems as well as the preeclampsia that may occur during pregnancy. - Anti-Fibrotic Properties - Blood Vessel Protection - Acute heart failure - Lung inflammation   Total Spray: 82 (244 mcg per spray) FRESHLY PREPARED SOLUTION

Chonluten is a peptide that regulates gene expression and is short in length. According to research, it is primarily active in the tissue of the lungs, with only secondary levels of activity being found in the GI tract. Chonluten's ability to regulate pulmonary mucosal function could be particularly useful in the treatment of chronic inflammatory lung illnesses including asthma, COPD, and in acute and chronic respiratory disorders of infectious and non-infectious origin, as well as for preserving the function of the respiratory system in older patients. Chonluten has been shown to have effects on: - After pneumonia - Chronic cardiopulmonary insufficiency - Chronic respiratory failure - After prolonged artificial ventilation - Pulmonary tuberculosis in remission - In case of respiratory distress syndrome - Intense sports - To maintain the function of the respiratory system in elderly - Asthma - Crohn’s disease and Ulcerative Colitis.   Total Spray: 82 (609 mcg per spray) FRESHLY PREPARED SOLUTION

Chonluten is a peptide that regulates gene expression and is short in length. According to research, it is primarily active in the tissue of the lungs, with only secondary levels of activity being found in the GI tract. Chonluten's ability to regulate pulmonary mucosal function could be particularly useful in the treatment of chronic inflammatory lung illnesses including asthma, COPD, and in acute and chronic respiratory disorders of infectious and non-infectious origin, as well as for preserving the function of the respiratory system in older patients. Chonluten has been shown to have effects on: - After pneumonia - Chronic cardiopulmonary insufficiency - Chronic respiratory failure - After prolonged artificial ventilation - Pulmonary tuberculosis in remission - In case of respiratory distress syndrome - Intense sports - To maintain the function of the respiratory system in elderly - Asthma - Crohn’s disease and Ulcerative Colitis.

Antioxidant, Anti-aging, Cataracts, Glaucoma, Alcoholism, Asthma, Cancer, Diseases of the heart and blood vessels, Liver disease, Chronic Fatigue Syndrome, Thyroiditis, Boosting the immune system, Memory loss, Alzheimer’s disease, Osteoarthritis, Autoimmune diseases, Parkinson’s disease, Detoxifying metals and drugs, Cystic fibrosis, For preventing toxicity of chemotherapy.